Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Comparison of drug holiday from adhd in taiwan and international experience
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: WU, Tsung Hsien (Taipei City Hospital)
- Co-author(s): Tsung Hsien Wu
BackgroundAttention-deficit/hyperactivity disorder (ADHD) is a developmental disorder that affects approximately one in 20 children. Medication is a first-line effective treatment for ADHD. Common options are immediate-release methylphenidate(IR-MPH) 、the osmotic controlled –release formulation of methylphenidate(OROS-MPH), and atomoxetine(ATX).
Met.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019